NASDAQ: INMB - INmune Bio, Inc.

Altı ay boyunca karlılık: -42.38%
Sektör: Healthcare

Promosyon programı INmune Bio, Inc.

Gelişmiş program Basit grafik
Financial Markets by TradingView

Şirket hakkında

INmune Bio, Inc., a clinical-stage immunology company, focuses on reprogramming the patient's innate immune system to treat cancer and neurodegenerative diseases. It intends to develop and commercialize product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation.

daha fazla ayrıntı
The company's development programs include INKmune, which focuses on treating women with relapse refractory ovarian carcinoma solid tumor and patients with high-risk myelodysplastic syndrome; INB03 to treat patients with cancers that express MUC4, a mucinous polyglucan on the surface of some epithelial cancer cells that appears to predict resistant to immunotherapy, including women with MUC4 expressing HER2+ breast cancer and other MUC4 resistant cancers; and XPro1595 for the treatment of Alzheimer's disease and Treatment Resistant Depression. It has license agreements with Xencor, Inc.; Immune Ventures, LLC; and University of Pittsburg. The company was incorporated in 2015 and is headquartered in Boca Raton, Florida.
Karşılaştırma listesine ekle
İzleme listesine ekle
Portföye ekle
Fiyat bildirimi ekle

IPO date 2019-02-04
ISIN US45782T1051
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.inmunebio.com
Цена ао 11.88
Günlük fiyat değişimi: -1.69% (4.73)
Haftalık fiyat değişimi: +5.68% (4.4)
Aylık fiyat değişimi: -4.91% (4.89)
3 ayda fiyat değişimi: -10.92% (5.22)
Altı ayda fiyat değişimi: -42.38% (8.07)
Yıllık fiyat değişimi: -58.7% (11.26)
3 yılda fiyat değişimi: -56.38% (10.66)
5 yılda fiyat değişimi: +15.38% (4.03)
10 yılda fiyat değişimi: 0% (4.65)
Yılbaşından bu yana fiyat değişimi: -5.1% (4.9)
Tüm parametreler

Hafife alma

İsim Anlam Seviye
P/S 1220.37 1
P/BV 4.96 3
P/E 0 0
EV/EBITDA -5.51 0
Toplam: 2.63

Yeterlik

İsim Anlam Seviye
ROA, % -52.64 0
ROE, % -78.68 0
Toplam: 0

Temettüler

İsim Anlam Seviye
Div yield, % 0 0
DSI 0 0
Toplam: 0

Görev

İsim Anlam Seviye
Debt/EBITDA -0.3509 10
Toplam: 9.8

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % -99.8 0
karlılık Ebitda, % 175.38 10
karlılık EPS, % 87.52 9
Toplam: 7.8
Daha fazla ayrıntı

Kurumlar Hacim Paylaşmak, %
Vanguard Group Inc 541329 3
Blackrock Inc. 257929 1.43
Rhenman & Partners Asset Management AB 178284 0.99
Geode Capital Management, LLC 170040 0.94
Janney Montgomery Scott LLC 163559 0.91
Deutsche Bank Aktiengesellschaft 109848 0.61
MAI Capital Management 98012 0.54
Quadrant Capital Group LLC 60000 0.33
Royal Bank of Canada 57791 0.32
State Street Corporation 45063 0.25

ETF Paylaşmak, % Yıllık karlılık, % Temettüler, %
iShares Micro-Cap ETF 0.01798 13.79 1.54048
Vanguard Russell 2000 Growth ETF 0.01 17.39 0.60264
iShares Russell 2000 Growth ETF 0.0057 38.04 0.6026
ProShares UltraPro Russell2000 0.00138 89.82 1.47873
ProShares Hedge Replication ETF 0.00039 5.92 1.47892
Avantis U.S Small Cap Equity ETF 0.00028 27.77 1.68271
Vanguard Russell 3000 ETF 0 31.87 1.43817
Vanguard Russell 2000 ETF 0 14.37 1.48801



Süpervizör İş unvanı Ödeme Doğum yılı
Dr. Raymond Joseph Tesi M.D. Co-Founder, President, CEO, Chief Medical Officer & Chairman 500.5k 1956 (69 yıllar)
Mr. David J. Moss M.B.A. CFO, Treasurer & Secretary 394.9k 1970 (55 yıllar)
Dr. Mark William Lowdell BSc, FRCPath, MICR, MSc, Ph.D. Chief Scientific Officer & Chief Manufacturing Officer 150.24k 1963 (62 yıl)
Mr. Joshua S. Schoonover Esq. General Counsel N/A

Adres: United States, Boca Raton. FL, 225 NE Mizner Blvd. - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.inmunebio.com